Asuragen Scientific Publications

Asuragen has researched and published extensively in genetics, oncology, molecular diagnostics, and technology advancements for over 15 years. These publications, posters, and white papers cover various disease areas and their related genes including fragile X (FMR1), spinal muscular atrophy (SMN1/SMN2), cystic fibrosis (CFTR), and chronic myeloid leukemia (BCR-ABL1). They show the power of detecting and interpreting molecular alterations using AmplideX and QuantideX technologies as well as the value of Molecular Quality Controls and companion diagnostics collaborations to deliver new insights and advance precision medicine. Simply search by term, filter by category, or use both to find your area of interest.

We’re driven to provide people with better answers, so we ensure our products are supported by reliable data and backed by rigorous science. Dive into these publications to learn more.

Verification of Software and Amplification-Based Nanopore Sequencing Solution to Characterize Complex Variants in 11 Challenging, High-Frequency Carrier Genes
Juliette Baker
Beta evaluation of AmplideX® PCR enrichement technology with Nanopore long-read DNA sequencing of a panel of eleven challenging genes
Lebre A.S.
Verification of a Highly Sensitive, Circulating Cell-Free DNA and Exosomal RNA RT-qPCR Assay System to Monitor ESR1 Mutations from a Liquid Biopsy
Kevin Kelnar, Blaine Caughron, Holli Dale, Melissa Church, Julie R Thibert, Jamie Myers, Sarah Statt, and Brian C Haynes
Verification of an Amplification Based Nanopore Sequencing Assay and Software to Genotype Complex, Clinically-Relevant Variants in 11 Hard-to-Decipher Genes with High Carrier Frequencies
Connor A. Parker, Jonathan Turner, Brennan Greenlee, Juliette A. Baker, Walairat L. Wolf, Christopher J. Fraher, Monica Roberts, Theodore Markulin, Eduardo Priego, Mahesh Yarasi, Mia K. Mihailovic, Bryan J. Killinger, Brian C. Haynes, Bradley Hall, and Ashima Sharma
Freeze-Dried, Worry Thawed: Armored RNA new Lyophilized Controls Offer Potential to Advance Molecular Testing in Resource-Limited Settings
Deepa Eveleigh, Erica Frew, Frank Hui, and Raymond Lu
Verification of an RT-qPCR Assay System for Liquid Biopsy Surveillance of Treatment-Resistant ESR1 Mutations
Blaine Caughron, Melissa Church, Holli Dale, Jamie Myers, Julie R Thibert, Brian C Haynes, Sarah Statt, Kevin Kelnar
Resolving Complex Genotypes in Residual Clinical Samples with Long Range-PCR and Nanopore Sequencing Assay
Cody Edwards, Bryan Killinger, Andrew Laurie, Lisa Hsu, Anne-Sophie Lebre, Tony Yammine, Chandler Ho, Tsoyu Chiang, Ilona Volkova, Monica Roberts, Theodore Markulin, Mia Mihailovic, Eduardo Priego, Brian C. Haynes, Bradley Hall
An Exosome-based ESR1 Monitoring RT-qPCR Kit That Rapidly and Accurately Detects Acquired Resistance Variants at ≤ 0.1% Frequency in Liquid Biopsy Samples
Sarah Statt, Julie R Thibert, Melissa Church, Jamie Myers1, Holli Dale, Blaine Caughron, Kevin Kelnar, and Brian Haynes
Combining AmplideX® PCR Chemistries, Nanopore Sequencing, and Automated Analysis Software to Genotype Complex, Clinically-relevant Variants in 11 Challenging Targets Associated with Hereditary Diseases
John N. Milligan, Bryan J. Killinger, Cody Edwards, Christopher J. Fraher, Jon Kemppainen, Monica Roberts, Jonathan Turner, Theodore Markulin, Brennan Greenlee, Eduardo Priego, Juliette A. Baker, Mahesh Yarasi, Connor Parker, Mia K. Mihailovic, Ashima Sharma, Brian C. Haynes, and Bradley Hall
Beta evaluation of AmplideX® PCR enrichement technology with Nanopore long-read DNA sequencing of a panel of eleven challenging genes
Feyereisen L, Yammine T, Landais E, Moret H, Audrézet M-P, Bonello-Palot N, Rouzier C, Pissard S, Gueguen P, Metay C, Froissart R, Bekri S, Bellanné-Chantelot C, Lebre AS
Search
Filter

Publication Categories

Publication Types

Clear All Filters
Back To
Top